Page 3«..2345..1020..»

Category Archives: Muscular Dystrophy Treatment

Becker Muscular Dystrophy Treatment Market Size, Trends, Analysis, Future Scope and Demand Forecast to 2028 l Key Players: SANTHERA PHARMACEUTICALS,…

Posted: Published on December 17th, 2021

Becker Muscular Dystrophy Treatment Market report contains key data about the market, emerging trends, product usage, motivating factors for customers and competitors. This is a detailed market research report that serves this purpose and gives the business a competitive advantage. The excellent market report evaluates the existing state of the market, market size and market share, revenue generated from the product sale, and essential changes required in the future products. Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Becker Muscular Dystrophy Treatment Market Size, Trends, Analysis, Future Scope and Demand Forecast to 2028 l Key Players: SANTHERA PHARMACEUTICALS,…

Elamipretide as Add-on May Boost Efficacy of Exon-skipping Therapies – Muscular Dystrophy News

Posted: Published on December 17th, 2021

Elamipretide, an investigational therapy designed to increase the activity of mitochondria, may boost the effectiveness of exon-skipping therapies for Duchenne muscular dystrophy (DMD), its developer,Stealth BioTherapeutics, reported. Our new preclinical data increases our optimism that elamipretide may help address the unmet need for therapies in DMD, Reenie McCarthy, the CEO of Stealth, said in a press release. Mitochondria are often referred to as the powerhouses of the cell, because they are critical for energy generation Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Elamipretide as Add-on May Boost Efficacy of Exon-skipping Therapies – Muscular Dystrophy News

Directed Evolution Improves Gene Therapy Vector for… : Neurology Today – LWW Journals

Posted: Published on December 17th, 2021

By Richard Robinson December 16, 2021 The Science Explained Article In Brief A new gene delivery vector and methodology called directed evolution enables more potent delivery of corrective genes to the muscles in mice and primate models, and holds promise for reducing the cost and risk of treatment for muscle disorders. A new gene delivery vector, building on over 20 years of basic virology research, holds promise for accelerating gene therapy research and reducing the cost and risk of treatment, according to a paper published September 16 in the journal Cell Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Directed Evolution Improves Gene Therapy Vector for… : Neurology Today – LWW Journals

Current & Future State Of Gene Therapy – Contract Pharma

Posted: Published on December 17th, 2021

Sheila Mikhail, CEO and Co-Founder of AskBio, was recently named EYs 2021 Entrepreneur Of The Year National Overall Award winner. The preeminent competitive awards recognize the unstoppable entrepreneurs transforming our world. Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Current & Future State Of Gene Therapy – Contract Pharma

Edgewise Therapeutics to Report Phase 1b Topline Results of EDG-5506 in Individuals with Becker Muscular Dystrophy (BMD) on January 5, 2022, and…

Posted: Published on December 17th, 2021

Country United States of America US Virgin Islands United States Minor Outlying Islands Canada Mexico, United Mexican States Bahamas, Commonwealth of the Cuba, Republic of Dominican Republic Haiti, Republic of Jamaica Afghanistan Albania, People's Socialist Republic of Algeria, People's Democratic Republic of American Samoa Andorra, Principality of Angola, Republic of Anguilla Antarctica (the territory South of 60 deg S) Antigua and Barbuda Argentina, Argentine Republic Armenia Aruba Australia, Commonwealth of Austria, Republic of Azerbaijan, Republic of Bahrain, Kingdom of Bangladesh, People's Republic of Barbados Belarus Belgium, Kingdom of Belize Benin, People's Republic of Bermuda Bhutan, Kingdom of Bolivia, Republic of Bosnia and Herzegovina Botswana, Republic of Bouvet Island (Bouvetoya) Brazil, Federative Republic of British Indian Ocean Territory (Chagos Archipelago) British Virgin Islands Brunei Darussalam Bulgaria, People's Republic of Burkina Faso Burundi, Republic of Cambodia, Kingdom of Cameroon, United Republic of Cape Verde, Republic of Cayman Islands Central African Republic Chad, Republic of Chile, Republic of China, People's Republic of Christmas Island Cocos (Keeling) Islands Colombia, Republic of Comoros, Union of the Congo, Democratic Republic of Congo, People's Republic of Cook Islands Costa Rica, Republic of Cote D'Ivoire, Ivory Coast, Republic of the Cyprus, Republic of Czech Republic Denmark, Kingdom of Djibouti, Republic of Dominica, Commonwealth of Ecuador, Republic of Egypt, Arab Republic of El Salvador, Republic of Equatorial Guinea, Republic of Eritrea Estonia Ethiopia Faeroe Islands Falkland Islands (Malvinas) Fiji, Republic of the Fiji Islands Finland, Republic of France, French Republic French Guiana French Polynesia French Southern Territories Gabon, Gabonese Republic Gambia, Republic of the Georgia Germany Ghana, Republic of Gibraltar Greece, Hellenic Republic Greenland Grenada Guadaloupe Guam Guatemala, Republic of Guinea, Revolutionary People's Rep'c of Guinea-Bissau, Republic of Guyana, Republic of Heard and McDonald Islands Holy See (Vatican City State) Honduras, Republic of Hong Kong, Special Administrative Region of China Hrvatska (Croatia) Hungary, Hungarian People's Republic Iceland, Republic of India, Republic of Indonesia, Republic of Iran, Islamic Republic of Iraq, Republic of Ireland Israel, State of Italy, Italian Republic Japan Jordan, Hashemite Kingdom of Kazakhstan, Republic of Kenya, Republic of Kiribati, Republic of Korea, Democratic People's Republic of Korea, Republic of Kuwait, State of Kyrgyz Republic Lao People's Democratic Republic Latvia Lebanon, Lebanese Republic Lesotho, Kingdom of Liberia, Republic of Libyan Arab Jamahiriya Liechtenstein, Principality of Lithuania Luxembourg, Grand Duchy of Macao, Special Administrative Region of China Macedonia, the former Yugoslav Republic of Madagascar, Republic of Malawi, Republic of Malaysia Maldives, Republic of Mali, Republic of Malta, Republic of Marshall Islands Martinique Mauritania, Islamic Republic of Mauritius Mayotte Micronesia, Federated States of Moldova, Republic of Monaco, Principality of Mongolia, Mongolian People's Republic Montserrat Morocco, Kingdom of Mozambique, People's Republic of Myanmar Namibia Nauru, Republic of Nepal, Kingdom of Netherlands Antilles Netherlands, Kingdom of the New Caledonia New Zealand Nicaragua, Republic of Niger, Republic of the Nigeria, Federal Republic of Niue, Republic of Norfolk Island Northern Mariana Islands Norway, Kingdom of Oman, Sultanate of Pakistan, Islamic Republic of Palau Palestinian Territory, Occupied Panama, Republic of Papua New Guinea Paraguay, Republic of Peru, Republic of Philippines, Republic of the Pitcairn Island Poland, Polish People's Republic Portugal, Portuguese Republic Puerto Rico Qatar, State of Reunion Romania, Socialist Republic of Russian Federation Rwanda, Rwandese Republic Samoa, Independent State of San Marino, Republic of Sao Tome and Principe, Democratic Republic of Saudi Arabia, Kingdom of Senegal, Republic of Serbia and Montenegro Seychelles, Republic of Sierra Leone, Republic of Singapore, Republic of Slovakia (Slovak Republic) Slovenia Solomon Islands Somalia, Somali Republic South Africa, Republic of South Georgia and the South Sandwich Islands Spain, Spanish State Sri Lanka, Democratic Socialist Republic of St. Helena St Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Edgewise Therapeutics to Report Phase 1b Topline Results of EDG-5506 in Individuals with Becker Muscular Dystrophy (BMD) on January 5, 2022, and…

These Healthcare Stocks Lagged This Year, But Might Offer Deep Value – Trefis

Posted: Published on December 17th, 2021

Our theme ofOut Of Favor Health Care Stocksincludes healthcare and pharmaceutical stocks that are seeing a disconnect between their financial performance and recent stock price returns. Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on These Healthcare Stocks Lagged This Year, But Might Offer Deep Value – Trefis

New Gene-Writing Tool Helps To Develop Advanced Gene Therapies – Technology Networks

Posted: Published on December 17th, 2021

An international, multidisciplinary team of researchers from theTranslational Synthetic Biology Laboratoryat Pompeu Fabra University (Barcelona, Spain), led by Dr.Marc Gell, has published an article in the scientific journalNature Communicationsshowing the potential of Find Cut-and-Transfer (FiCAT) technology as a state-of-the-art tool forgene writingto develop advanced therapies that are safer and more effective in their future clinical application in patients withgenetic and oncological diseasesthat have few treatment options. Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on New Gene-Writing Tool Helps To Develop Advanced Gene Therapies – Technology Networks

‘This is a desperate plea from a desperate mother. My boys are getting weaker every day’ – Irish Examiner

Posted: Published on December 17th, 2021

As children across the country count the sleeps until Santa Claus arrives, three Roscommon children with terminal conditions are hoping they will be able to move into their new home soon. Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on ‘This is a desperate plea from a desperate mother. My boys are getting weaker every day’ – Irish Examiner

Q&A: Dr. Thomas Rando on preventing age-related diseases and turning discoveries into cures – UCLA Newsroom

Posted: Published on December 17th, 2021

For Dr. Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Q&A: Dr. Thomas Rando on preventing age-related diseases and turning discoveries into cures – UCLA Newsroom

First BMD Patients Dosed in Trial of Oral Therapy EDG-5506 – Muscular Dystrophy News

Posted: Published on November 5th, 2021

A Phase 1 clinical trial evaluating Edgewise Therapeutics experimental oral therapy EDG-5506 in healthy volunteers and men with Becker muscular dystrophy (BMD) has dosed the first BMD patients. The study (NCT04585464) is currently recruiting up to eight men, ages 18 to 55, with BMD at its single site in San Antonio, Texas; more information can be foundhere. Top-line data from these patients are expected by the end of the year Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on First BMD Patients Dosed in Trial of Oral Therapy EDG-5506 – Muscular Dystrophy News

Page 3«..2345..1020..»